Target Price | CHF665.52 |
Price | CHF583.60 |
Potential | 14.04% |
Number of Estimates | 23 |
23 Analysts have issued a price target Lonza 2026 . The average Lonza target price is CHF665.52. This is 14.04% higher than the current stock price. The highest price target is CHF744.00 27.48% , the lowest is CHF600.00 2.81% . | |
A rating was issued by 27 analysts: 22 Analysts recommend Lonza to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lonza stock has an average upside potential 2026 of 14.04% . Most analysts recommend the Lonza stock at Purchase. |
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 6.57 | 7.68 |
2.13% | 16.79% | |
EBITDA Margin | 26.36% | 28.68% |
20.05% | 8.80% |
24 Analysts have issued a sales forecast Lonza 2025 . The average Lonza sales estimate is CHF7.7b . This is 16.79% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.0b 21.14% , the lowest is CHF6.6b 0.40% .
This results in the following potential growth metrics:
2024 | CHF6.6b | 2.13% |
---|---|---|
2025 | CHF7.7b | 16.79% |
2026 | CHF8.5b | 10.99% |
2027 | CHF9.5b | 11.90% |
2028 | CHF10.7b | 12.00% |
2029 | CHF11.7b | 9.51% |
24 Analysts have issued an Lonza EBITDA forecast 2025. The average Lonza EBITDA estimate is CHF2.2b . This is 47.81% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF2.3b 55.91% , the lowest is CHF1.9b 28.30% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF1.7b | 17.49% |
---|---|---|
2025 | CHF2.2b | 27.09% |
2026 | CHF2.5b | 15.35% |
2027 | CHF2.9b | 15.62% |
2028 | CHF3.4b | 14.25% |
2029 | CHF3.9b | 17.36% |
2024 | 26.36% | 20.05% |
---|---|---|
2025 | 28.68% | 8.80% |
2026 | 29.81% | 3.94% |
2027 | 30.80% | 3.32% |
2028 | 31.42% | 2.01% |
2029 | 33.67% | 7.16% |
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 8.93 | 14.70 |
0.56% | 64.61% | |
P/E | 39.71 | |
EV/Sales | 5.74 |
20 Analysts have issued a Lonza forecast for earnings per share. The average Lonza <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is CHF14.70 . This is 64.61% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is CHF16.20 81.41% , the lowest is CHF13.26 48.49% .
This results in the following potential growth metrics and future valuations:
2024 | CHF8.93 | 0.56% |
---|---|---|
2025 | CHF14.70 | 64.61% |
2026 | CHF17.86 | 21.50% |
2027 | CHF21.46 | 20.16% |
2028 | CHF27.42 | 27.77% |
2029 | CHF35.56 | 29.69% |
Current | 65.35 | 26.94% |
---|---|---|
2025 | 39.71 | 39.23% |
2026 | 32.68 | 17.70% |
2027 | 27.20 | 16.77% |
2028 | 21.29 | 21.73% |
2029 | 16.41 | 22.92% |
Based on analysts' sales estimates for 2025, the Lonza stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.74 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 5.35 .
This results in the following potential growth metrics and future valuations:
Current | 6.71 | 28.30% |
---|---|---|
2025 | 5.74 | 14.40% |
2026 | 5.17 | 9.90% |
2027 | 4.62 | 10.64% |
2028 | 4.13 | 10.71% |
2029 | 3.77 | 8.69% |
Current | 6.24 | 23.50% |
---|---|---|
2025 | 5.35 | 14.38% |
2026 | 4.82 | 9.90% |
2027 | 4.30 | 10.64% |
2028 | 3.84 | 10.71% |
2029 | 3.51 | 8.68% |
Analyst | Rating | Action | Date |
---|---|---|---|
KEYBANC CAPITAL MARKETS INC. | Overweight ➜ Overweight | Unchanged | Jan 05 2025 |
BERENBERG | Buy ➜ Buy | Unchanged | Jan 02 2025 |
RESEARCH PARTNERS AG | Buy ➜ Buy | Unchanged | Dec 15 2024 |
EQUITA SIM | Buy ➜ Hold | Downgrade | Dec 12 2024 |
STIFEL EUROPE | Hold ➜ Hold | Unchanged | Dec 11 2024 |
WILLIAM BLAIR & COMPANY | Outperform ➜ Outperform | Unchanged | Dec 11 2024 |
ODDO BHF | Buy ➜ Buy | Unchanged | Dec 11 2024 |
Analyst Rating | Date |
---|---|
Unchanged
KEYBANC CAPITAL MARKETS INC.: Overweight ➜ Overweight
|
Jan 05 2025 |
Unchanged
BERENBERG: Buy ➜ Buy
|
Jan 02 2025 |
Unchanged
RESEARCH PARTNERS AG: Buy ➜ Buy
|
Dec 15 2024 |
Downgrade
EQUITA SIM: Buy ➜ Hold
|
Dec 12 2024 |
Unchanged
STIFEL EUROPE: Hold ➜ Hold
|
Dec 11 2024 |
Unchanged
WILLIAM BLAIR & COMPANY: Outperform ➜ Outperform
|
Dec 11 2024 |
Unchanged
ODDO BHF: Buy ➜ Buy
|
Dec 11 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.